232 filings
Page 3 of 12
8-K
3rlo9 mjv0vqvzm1haje
3 Sep 20
Entry into a Material Definitive Agreement
8:37am
8-K
to8 ndp7hwdyzk
4 Aug 20
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
4:31pm
8-K
c6x9jqk
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
5lz fl4zw5bk
15 Jun 20
Departure of Directors or Certain Officers
4:31pm
8-K
7sjq6i9g64 s949nh
2 Jun 20
Regulation FD Disclosure
8:33am
8-K
98zg0j kr
18 May 20
Other Events
8:00am
8-K
nrb2vt
14 May 20
Submission of Matters to a Vote of Security Holders
8:00am
8-K
5g71bb o9b4w561lo8vk
1 May 20
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:10am
8-K
ds9rvf
21 Apr 20
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
8:00am
8-K
t7vznbzkb4jyytf81
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
rggi1 ueksqx9fcgeva3
12 Mar 20
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
7:49am
8-K
8iz6 y55xqc
5 Mar 20
Regulation FD Disclosure
8:00am
8-K
16k6ftc1w
27 Jan 20
Departure of Directors or Certain Officers
5:10pm
8-K
i0kuzzctj35b9y
15 Jan 20
38 th Annual JP Morgan Healthcare Conference
7:05am
8-K
5uxfg
14 Jan 20
Regulation FD Disclosure
7:05am
8-K
e3uij2rgmrg88p
23 Dec 19
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
4:01pm
8-K
ga2w9a4ueol9gew2
6 Nov 19
Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:13pm
8-K
o0usi8z1x5
31 Oct 19
October 2019 Corporate Update
5:14pm
8-K
bktp7pj8
4 Sep 19
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
7:05am
8-K
foiahxc
29 Aug 19
Regulation FD Disclosure
4:03pm